IRD

Opus Genetics, Inc. Common Stock

$4.12 -5.50%

Recent alerts on IRD

All signals →

Insider trade Sale by Foundation Fighting Blindness Retinal Degeneration Fund

Insider trade Sale by Foundation Fighting Blindness, Inc.

SEC filing IRD Reports $43.6M Cash, Advances LCA5, BEST1 Gene Therapies, Expected Runway into 2029

Insider trade Sale by Joseph K Schachle (Chief Operating Officer)

Insider trade Sale by Rabourn Amy Zaremba (Head of Fin. Quality Assurance)

Insider trade Sale by George Magrath (Chief Executive Officer)

Insider trade Sale by Benjamin R Yerxa (President)

Insider trade Sale by Ashwath Jayagopal (Chief Scientific & Dev. Ofc.)

Insider trade Sale by Robert E. Gagnon (Chief Financial Officer)

Insider trade Sale by Joseph K Schachle (Chief Operating Officer)

Insider trade Sale by Rabourn Amy Zaremba (Head of Fin. Quality Assurance)

Insider trade Sale by George Magrath (Chief Executive Officer)

Insider trade Sale by Ashwath Jayagopal (Chief Scientific & Dev. Ofc.)

News Opus Genetics higher after $25M private placement

Scanner Unusual volume (8.1x average)

Get push alerts for IRD

Add it to your watchlist in the app and receive every signal the moment it fires.

Download for iOS

Download for iOS